HMP CommunicationsIbrutinib May Improve Pulmonary Outcomes in Certain COVID-19 Cases
Although the findings reported in Blood should be considered as hypothesis-generating and preliminary in nature, a small clinical trial suggested ibrutinib may protect against lung injury and improve pulmonary function in hypoxic patients with COVID-19.